Literature DB >> 30985435

Monoamine Oxidase B Binding of 18F-THK5351 to Visualize Glioblastoma and Associated Gliosis: An Autopsy-Confirmed Case.

Tetsuro Tago, Jun Toyohara, Renpei Sengoku, Shigeo Murayama, Kenji Ishii.   

Abstract

An 86-year-old woman with cognitive impairment and left hemiparesis underwent F-THK5351 PET 4 months before her death. In addition to "normal" off-target binding in the basal ganglia, abnormal accumulation was observed along the pyramidal tract and around the right basal ganglia as ring-shaped uptake that overlapped a gadolinium-enhanced lesion. Postmortem pathological examination revealed that she had glioblastoma multiforme with associated gliosis, in which monoamine oxidase B (MAO-B) activity is increased. In vitro autoradiography of the corresponding lesion demonstrated specific binding of F-THK5351, which was blocked by an MAO-B-selective ligand. Thus, F-THK5351 PET may reflect glioblastomas and associated gliosis by binding to MAO-B.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30985435     DOI: 10.1097/RLU.0000000000002564

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies.

Authors:  Michinori Ezura; Akio Kikuchi; Nobuyuki Okamura; Aiko Ishiki; Takafumi Hasegawa; Ryuichi Harada; Shoichi Watanuki; Yoshihito Funaki; Kotaro Hiraoka; Toru Baba; Naoto Sugeno; Shun Yoshida; Junpei Kobayashi; Michiko Kobayashi; Ohito Tano; Shun Ishiyama; Takaaki Nakamura; Ichiro Nakashima; Shunji Mugikura; Ren Iwata; Yasuyuki Taki; Katsutoshi Furukawa; Hiroyuki Arai; Shozo Furumoto; Manabu Tashiro; Kazuhiko Yanai; Yukitsuka Kudo; Atsushi Takeda; Masashi Aoki
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

Review 2.  Imaging of Reactive Astrogliosis by Positron Emission Tomography.

Authors:  Ryuichi Harada; Shozo Furumoto; Yukitsuka Kudo; Kazuhiko Yanai; Victor L Villemagne; Nobuyuki Okamura
Journal:  Front Neurosci       Date:  2022-02-08       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.